Barclays Lowers Chemours (NYSE:CC) Price Target to $13.00
Chemours (NYSE:CC – Get Free Report) had its target price cut by Barclays from $16.00 to $13.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an “equal weight” rating on the specialty chemicals company’s stock. Barclays‘s price objective points to a potential upside of 28.52% from the […]
